Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7) - Harbeck, N; Franke, F; Villanueva-Vazquez, R (Ther Adv Med Oncol, 2020)